Liu, Qing-Hua <br/><br/>
Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer.  [electronic resource] 

 -  Investigational new drugs  04 2020 
 - 350-359 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-0646 
<br/><br/><label>Standard No.: </label>10.1007/s10637-019-00785-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism<br/>Animals<br/>Annexin A1--genetics<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Biomarkers, Tumor--genetics<br/>Cell Line, Tumor<br/>Deoxycytidine--analogs & derivatives<br/>Down-Regulation<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorouracil--pharmacology<br/>Humans<br/>MAP Kinase Kinase 4--metabolism<br/>Male<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Pancreatic Neoplasms--drug therapy<br/>Protein Kinase C--metabolism<br/>Signal Transduction<br/>Gemcitabine